Una triple combinación de terapias, hito "prometedor" para cáncer de mama

A triple combination of therapies, a “promising” milestone for breast cancer

Javier Cortés, doctor and first author of the same and director of the International Breast Cancer Center (IBCC). The International Breast Cancer Center (IBCC) has recently managed to give a hit of effect to treat patients with triple breast cancer advanced negative with PD-L1 expression. Combining immunotherapy, chemotherapy and the pembrolizumab drug even better 27 …

A triple combination of therapies, a “promising” milestone for breast cancer Read More »